# Adriana Balduzzi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/adriana-balduzzi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 14,218 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 47 |
| i10-index | 127 |
| Last Known Institution | Azienda Ospedaliera San Gerardo |
| OpenAlex ID | https://openalex.org/A5078858949 |
| ORCID iD | 0000-0002-5879-0610 |
| Works | 330 |

## Researcher papers

- [Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia](https://scholariq.org/papers/tisagenlecleucel-in-children-and-young-adults-with-b-cell-lymphoblastic-leukemia/)
- [Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial](https://scholariq.org/papers/three-year-update-of-tisagenlecleucel-in-pediatric-and-young-adult-patients-with/)
- [Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation](https://scholariq.org/papers/diagnosis-and-severity-criteria-for-sinusoidal-obstruction-syndrome-veno/)
- [Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study](https://scholariq.org/papers/total-body-irradiation-or-chemotherapy-conditioning-in-childhood-all-a/)
- [Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations](https://scholariq.org/papers/immune-effector-cell-associated-hematotoxicity-eha-ebmt-consensus-grading-and/)
- [Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation](https://scholariq.org/papers/response-to-rituximab-based-therapy-and-risk-factor-analysis-in-epstein-barr/)
- [Imatinib for refractory chronic graft-versus-host disease with fibrotic features](https://scholariq.org/papers/imatinib-for-refractory-chronic-graft-versus-host-disease-with-fibrotic-features/)
- [Unrelated donor marrow transplantation in children](https://scholariq.org/papers/unrelated-donor-marrow-transplantation-in-children/)
- [Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients](https://scholariq.org/papers/treatment-of-graft-versus-host-disease-with-mesenchymal-stromal-cells-a-phase-i/)
- [Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment](https://scholariq.org/papers/flash-survey-on-severe-acute-respiratory-syndrome-coronavirus-2-infections-in/)
- [Microwave ablation for large benign thyroid nodules: a proposal for a new approach: “the fluid-motion technique”](https://scholariq.org/papers/microwave-ablation-for-large-benign-thyroid-nodules-a-proposal-for-a-new/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Researcher university

- [Azienda Ospedaliera San Gerardo](https://scholariq.org/institutions/azienda-ospedaliera-san-gerardo/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.